CoN(S)taminant or Pathogen? Assessment and Analysis of Coagulase-Negative Staphylococcus Infections

<p>Michaela E. Wermers, Pharm.D., describes the epidemiology and pathogenicity of coagulase-negative Staphylococcus (CoNS) species, outlines an evidence-based approach to determine the clinical significance of CoNS isolates and identifies empiric and definitive treatment regimens for pathogenic CoNS. </p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>